Thyrocare Technologies Limited

NSEI:THYROCARE Stock Report

Market Cap: ₹53.7b

Thyrocare Technologies Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Rahul Guha

Chief executive officer

₹35.0m

Total compensation

CEO salary percentage40.00%
CEO tenure3yrs
CEO ownership0.1%
Management average tenure1.5yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Thyrocare Technologies' (NSE:THYROCARE) Solid Earnings Have Been Accounted For Conservatively

May 02
Thyrocare Technologies' (NSE:THYROCARE) Solid Earnings Have Been Accounted For Conservatively

After Leaping 26% Thyrocare Technologies Limited (NSE:THYROCARE) Shares Are Not Flying Under The Radar

Apr 26
After Leaping 26% Thyrocare Technologies Limited (NSE:THYROCARE) Shares Are Not Flying Under The Radar

The Returns On Capital At Thyrocare Technologies (NSE:THYROCARE) Don't Inspire Confidence

Apr 23
The Returns On Capital At Thyrocare Technologies (NSE:THYROCARE) Don't Inspire Confidence

Thyrocare Technologies Limited Just Missed Earnings - But Analysts Have Updated Their Models

Jan 28
Thyrocare Technologies Limited Just Missed Earnings - But Analysts Have Updated Their Models

Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are

Oct 31
Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are

Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump

Aug 01
Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump

Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Jul 26
Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Jun 12
A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Feb 29
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 04
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Dec 08
Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 08
Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Mar 23
Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Mar 02
Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

CEO Compensation Analysis

How has Rahul Guha's remuneration changed compared to Thyrocare Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

₹915m

Dec 31 2024n/an/a

₹877m

Sep 30 2024n/an/a

₹840m

Jun 30 2024n/an/a

₹776m

Mar 31 2024₹35m₹14m

₹708m

Dec 31 2023n/an/a

₹655m

Sep 30 2023n/an/a

₹648m

Jun 30 2023n/an/a

₹599m

Mar 31 2023₹32mn/a

₹645m

Compensation vs Market: Rahul's total compensation ($USD409.71K) is about average for companies of similar size in the Indian market ($USD383.28K).

Compensation vs Earnings: Rahul's compensation has been consistent with company performance over the past year.

CEO

Rahul Guha (46 yo)

3yrs
Tenure
₹35,000,004
Compensation

Mr. Rahul Franklin Guha serves as President of Operations at API Holdings Limited since 2024. He is Managing Director, Chief Executive Officer and Director of Thyrocare Technologies Limited from May 04, 20...

Leadership Team

NamePositionTenureCompensationOwnership
Rahul Guha
MD, CEO & Chairman3yrs₹35.00m0.10%
₹ 54.3m
Alok Jagnani
Chief Financial Officer1.8yrs₹5.55mno data
K. KallathiKumar
Chief Operating Officerno data₹9.32m0.0030%
₹ 1.6m
Pratik Hire
Head of Strategy & Investor Relationsno datano datano data
Brijesh Kumar
Company Secretary & Compliance Officerless than a yearno datano data
Nitin Chugh
Chief Commercial Officer1.3yrsno datano data
Aditya Shinde
Vice Presidentno data₹5.33m0.0020%
₹ 1.1m
Kapil Gupta
Strategy Managerno datano datano data
Preet Kaur
Vice President of Lab Operations & Qualityno datano datano data
1.5yrs
Average Tenure
41yo
Average Age

Experienced Management: THYROCARE's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Rahul Guha
MD, CEO & Chairman3yrs₹35.00m0.10%
₹ 54.3m
Indumati Gopinathan
Non-Executive Independent Director7.8yrs₹240.00kno data
Dharmil Sheth
Non-Executive & Non-Independent Director3.7yrsno datano data
Hardik Dedhia
Non Executive Director3.7yrsno datano data
Dhaval Shah
Non Executive Director3.6yrsno datano data
Prapti Gilada
Independent Director1.8yrs₹220.00kno data
Harshil Vora
Non-Executive Independent Director1.8yrs₹40.00kno data
Anandh Sundar
Independent Directorno datano datano data
Nishant Shah
Independent Directorless than a yearno datano data
3.3yrs
Average Tenure
36yo
Average Age

Experienced Board: THYROCARE's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/27 06:27
End of Day Share Price 2025/05/27 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Thyrocare Technologies Limited is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alka KatiyarBatlivala & Karani Securities India Pvt. Ltd.
Rahul AgarwalCGS International
Kameswari V. S. ChavaliFirstCall Research